News

As the world begins to open its borders, international travelers need to remain diligent of limitations and risks.

Derek Jones, VP Enterprise Strategy, Americas at Deputy, gives tips on staffing strategies.

W. Schuyler Jones, MD, and Manesh Patel, MD discuss the influences the aspirin-dosing cardiology trial may have on future studies.

The US has reached the 50% mark for vaccinations for adults.

Jordana Hoppe, MD, discusses the burden of cystic fibrosis on infants and children.

The treatment is also being studied for safety and efficacy in patients with Crohn’s disease.

The company expects to file for FDA authorization for the 12-17 year old population in June.

Multiple studies have found a decrease in CDI rates during the COVID-19 pandemic in comparison to previous years.

The EMDAC voted 10-7 to support the benefit-risks of teplizumab for delaying clinical type 1 diabetes.

Weekly number of opioid-related deaths increased 135% over study period.

A longer duration of medication use during pregnancy was linked to decreases in odds of overdose and preterm birth.

Esophageal cancer has a low survival rate largely due to advanced stage diagnosis.

Nearly two-thirds of patients had improved or resolved EIM after ustekinumab treatment.

A large proportion of IBS-C patients did not seek health care during the COVID-19 pandemic despite symptoms.

There was a notable association between the comorbid population and congestive heart failure exacerbations.

Arena Pharmaceuticals expects to move forward with later phase clinical trials testing etrasimod.

Patients with opioid-induced constipation had more frequent, painful constipation symptoms, compared to those with chronic idiopathic constipation.

Direct optical endoscopy are often underutilized in screenings for EAC.

Data show patients with IBD and pathogen produced a unique pathogen-specific microbiome.

Social determinants can play a large role in hindering patient readiness for adult care.

Dr. Evan Dellon said up to 8 biopsies for high risk patients could be beneficial in diagnosing different diseases impacting the esophagus.

Sucrase isomaltase deficiency is often overlooked symptom in adult patients with IBS-D.

COVID-19 patients with liver injuries are at a higher risk of mortality or lengthier hospital stays.

Data show nearly 1 in 10 patients with IBS-D in study were identified with SID.

Data show adverse events occurred in 6.67% in the cohort of patients with IBD.

Most of the data on vedolizumab has been limited by small sample sizes and short follow-up.

About a quarter of Cologuard's ordered by patients are deemed to be inappropriate.

Infections in patients with ulcerative colitis treated with ozanimod were mostly characterized as non-serious.